Pfizer head elected PhRMA board chairman
This article was originally published in SRA
Executive Summary
Jeffrey Kindler, the chairman and chief executive of Pfizer, has been elected board chairman of the US pharma industry association PhRMA. Mr Kindler, who joined Pfizer in 2002 and was named chief executive and chairman of the board in 2006, succeeds David Brennan, the chief executive and executive director of AstraZeneca.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents